Target Price | $340.68 |
Price | $300.70 |
Potential |
13.30%
register free of charge
|
Number of Estimates | 27 |
27 Analysts have issued a price target Insulet Corporation 2026 .
The average Insulet Corporation target price is $340.68.
This is
13.30%
register free of charge
$399.00
32.69%
register free of charge
$263.72
12.30%
register free of charge
|
|
A rating was issued by 32 analysts: 27 Analysts recommend Insulet Corporation to buy, 5 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Insulet Corporation stock has an average upside potential 2026 of
13.30%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 2.07 | 2.58 |
22.07% | 24.49% | |
EBITDA Margin | 18.81% | 21.92% |
9.03% | 16.52% | |
Net Margin | 20.19% | 12.07% |
66.11% | 40.22% |
28 Analysts have issued a sales forecast Insulet Corporation 2025 . The average Insulet Corporation sales estimate is
This results in the following potential growth metrics:
19 Analysts have issued an Insulet Corporation EBITDA forecast 2025. The average Insulet Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
27 Insulet Corporation Analysts have issued a net profit forecast 2025. The average Insulet Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 5.66 | 4.42 |
102.14% | 21.91% | |
P/E | 67.97 | |
EV/Sales | 8.41 |
27 Analysts have issued a Insulet Corporation forecast for earnings per share. The average Insulet Corporation EPS is
This results in the following potential growth metrics and future valuations:
Insulet Corporation...
Analyst | Rating | Action | Date |
---|---|---|---|
Truist Securities |
Locked
➜
Locked
|
Locked | Jun 16 2025 |
Goldman Sachs |
Locked
➜
Locked
|
Locked | May 30 2025 |
Raymond James |
Locked
➜
Locked
|
Locked | May 27 2025 |
Citigroup |
Locked
➜
Locked
|
Locked | May 22 2025 |
Wolfe Research |
Locked
➜
Locked
|
Locked | May 13 2025 |
Oppenheimer |
Locked
➜
Locked
|
Locked | May 09 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
Analyst Rating | Date |
---|---|
Locked
Truist Securities:
Locked
➜
Locked
|
Jun 16 2025 |
Locked
Goldman Sachs:
Locked
➜
Locked
|
May 30 2025 |
Locked
Raymond James:
Locked
➜
Locked
|
May 27 2025 |
Locked
Citigroup:
Locked
➜
Locked
|
May 22 2025 |
Locked
Wolfe Research:
Locked
➜
Locked
|
May 13 2025 |
Locked
Oppenheimer:
Locked
➜
Locked
|
May 09 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Apr 30 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.